Literature DB >> 15498891

The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats.

Hyung-Yul Lee1, Shuangping Zhao, P A Fields, O D Sherwood.   

Abstract

Relaxin promotes marked growth of the cervix during the second half of rat pregnancy, and this growth is accompanied by an increase in both epithelial and stromal cells. The objective of this study was to test the hypothesis that the extent to which relaxin promotes proliferation and inhibits apoptosis of cervical cells is greatest during late pregnancy in rats. The influence of neutralization of circulating relaxin by iv injection of 5 mg monoclonal antibody against rat relaxin (MCA1) was examined at 3-d intervals throughout the second half of pregnancy. Controls were injected with either 5 mg monoclonal antibody against fluorescein or 0.5 ml PBS vehicle. To evaluate cell proliferation, 5'-bromo-2-deoxyuridine was injected sc 8 h before cervixes were collected. Terminal deoxynucleotidyl transferase-mediated deoxyuridine 5'-triphosphate nick end-labeling and electron microscopy were used to detect apoptotic cells. Neutralization of relaxin with MCA1 decreased the rate of proliferation and increased the rate of apoptosis of cervical cells by d 13. However, the extent to which relaxin influenced these processes was greatest and dramatic by late pregnancy. In MCA1-treated rats on d 22 of pregnancy, the rates of proliferation of both epithelial and stromal cells were less than 20% those in controls, and the rates of apoptosis in epithelial cells and stromal cells were more than 10- and 3-fold, respectively, greater than those in controls. In conclusion, this study provides evidence that the extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498891     DOI: 10.1210/en.2004-0796

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

2.  The effect of relaxin on cell proliferation in mouse cervix requires estrogen receptor {alpha} binding to estrogen response elements in stromal cells.

Authors:  Lijuan Yao; Paul S Cooke; Daryl D Meling; Roger D Shanks; J Larry Jameson; O David Sherwood
Journal:  Endocrinology       Date:  2010-03-22       Impact factor: 4.736

3.  Relaxin acts on stromal cells to promote epithelial and stromal proliferation and inhibit apoptosis in the mouse cervix and vagina.

Authors:  LiJuan Yao; Alexander I Agoulnik; Paul S Cooke; Daryl D Meling; O David Sherwood
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

4.  Relative roles of the epithelial and stromal tissue compartment(s) in mediating the actions of relaxin and estrogen on cell proliferation and apoptosis in the mouse lower reproductive tract.

Authors:  Lijuan Yao; Alexander I Agoulnik; Paul S Cooke; Daryl D Meling; O David Sherwood
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

5.  miR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation.

Authors:  Lauren Anton; Ann DeVine; Luz-Jeannette Sierra; Amy G Brown; Michal A Elovitz
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

6.  Effect of relaxin and IGF-I on the pre-implantation development of Mongolian gerbil (Meriones unguiculatus) embryos in vitro.

Authors:  Mayumi Yoshida; Ryuichiro Obata; Hirotada Tsujii
Journal:  Reprod Med Biol       Date:  2009-01-06

7.  Effect of relaxin on the decidual cell reaction in the Mongolian gerbil (Meriones unguiculatus).

Authors:  Mayumi Yoshida; M S Hossain; K M A Tareq; Ryuichiro Obata; Hirotada Tsujii
Journal:  Reprod Med Biol       Date:  2009-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.